Alvotech Initiates Clinical Studies for AVT04, A Proposed Biosimilar to Stelara® (Ustekinumab)
- Written by Reporters
- Approximately 530 participants will be enrolled in a comparative, confirmatory efficacy and safety study for AVT04 in plaque psoriasis, across Central and Eastern European countries.
- AVT04 Pharmacokinetic (PK) comparability study in approximately 294 healthy volunteers is being conducted simultaneously in New Zealand and Australia.
- Ustekinumab is in...